Litcius/Paper detail

Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial

Ahmad Nofal, Hagar Nofal, Esam Alwirshiffani, Mohamed Ibrahim El-Ghareeb

2023Journal of the American Academy of Dermatology10 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHuman papillomavirus vaccineHuman papillomavirusDermatologyTolerabilityAdverse effectImmunotherapyCommon wartsInternal medicineCancerCervical cancerGardasilCervical Cancer and HPV ResearchGenital Health and DiseasePoxvirus research and outbreaks
Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial | Litcius